Objective Biotechnology, Inc.
Minneapolis, MN
- UEI
- GN5KBQRNCBA9
- CAGE
- 9HF79
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 225 Thomas Ave N Suite 50, Minneapolis, MN 55405, USA
- Website
- objectivebiotechnology.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase Order 75N98026P01694 | Office of Logisitics and Acquisition Operations | $76,000 | |
| Assessor feedback PDF next-generation crispr gene drives | Defense Advanced Research Projects Agency | $682,453 | |
| High performance miniaturized microscopes for through skull cortex-wide imaging in freely behaving mice - project… | Aggregate Financial Assistance Data | $803,099 | |
| Computer vision guided automated microinjection robot | National Heart Lung and Blood Institute | $75,000 | |
| A computer-vision guided automated microinjection system with increased robustness, throughput, and generalizability… | Aggregate Financial Assistance Data | $1,200,472 |
About Objective Biotechnology, Inc.
Objective Biotechnology, Inc., a Minneapolis-based minority-owned for-profit biotechnology company, operates as a prime contractor on federal research and development awards in life-sciences automation and advanced biotech, with no subcontracting footprint and full exposure concentrated in civilian health research and defense R&D agencies.
Objective Biotechnology is a University of Minnesota spin-out pioneering machine vision–guided robotic automation for precise biological procedures, chiefly microinjection and gene-drive development. The vendor's federal footprint encompasses four prime awards totaling $757 thousand in combined potential value, though obligated dollars run to $1.5 million (194% of potential value), suggesting accelerated spend-down on early-stage R&D work. All four awards are prime awards; the vendor has taken no subcontract role.
Customer concentration centers on the National Institutes of Health and the Defense Advanced Research Projects Agency. The NIH Office of the Director holds two awards, including a $416,925 Phase I Small Business Technology Transfer (STTR) Project Grant (CFDA 93.351) under the Research Infrastructure Programs, awarded September 15, 2025, supporting development and commercialization of the mini-mscope, a 3.8-gram miniaturized imaging device for mesoscale cortex-wide neural activity measurement in freely behaving mice through intact skull imaging without craniotomy. A second NIH award, a $75 thousand firm fixed price purchase order from the National Heart Lung and Blood Institute awarded September 11, 2024, procured a computer vision–guided automated microinjection robot. DARPA anchors the dollar ranking with an Other Transaction Agreement, awarded February 20, 2026, for $682,454 funding next-generation CRISPR gene drives targeting invasive fly species, with performance and completion in Minneapolis by November 19, 2026. A third NIH award—a Project Grant for machine vision–guided robotics automating microinjections into fruit fly embryos, awarded September 1, 2024, and completing November 30, 2025—rounds out the active set.
Two awards (combined potential value $682 thousand) reach ultimate completion within the next twenty-four months and face recompete exposure. The vendor does not sit on government-wide vehicles (GWACs, BPAs, or agency-wide IDIQs) and competes full-and-open on civilian and defense R&D bases, with no set-aside designation in recent activity.
Quick answers
What is Objective Biotechnology, Inc.'s UEI?
Objective Biotechnology, Inc.'s Unique Entity ID (UEI) in SAM.gov is GN5KBQRNCBA9.
What is Objective Biotechnology, Inc.'s CAGE code?
Objective Biotechnology, Inc.'s CAGE code is 9HF79.
What is Objective Biotechnology, Inc.'s primary NAICS code?
Objective Biotechnology, Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
Where is Objective Biotechnology, Inc. located?
Objective Biotechnology, Inc.'s physical address in SAM.gov is 225 Thomas Ave N Suite 50, Minneapolis, MN 55405, USA.
Is Objective Biotechnology, Inc. registered in SAM.gov?
Yes. Objective Biotechnology, Inc.'s SAM.gov registration is active through April 22, 2027.
What is Objective Biotechnology, Inc.'s most recent federal award?
Objective Biotechnology, Inc.'s most recent federal contract award is Purchase Order 75N98026P01694 (75N98026P01694), from Office of Logisitics and Acquisition Operations, on September 16, 2026.
On GovTribe
See Objective Biotechnology, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors